Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022). (Q37329315)
Jump to navigation
Jump to search
scientific article published on 19 September 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022). |
scientific article published on 19 September 2013 |
Statements
1 reference
Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022). (English)
1 reference
Maryam Fouladi
1 reference
Henry S Friedman
1 reference
Sridharan Gururangan
1 reference
Roger E McLendon
1 reference
Richard J Gilbertson
1 reference
Larry E Kun
1 reference
Arzu Onar-Thomas
1 reference
Jason Fangusaro
1 reference
Tina Young Poussaint
1 reference
Katherine E Warren
1 reference
Shengjie Wu
1 reference
Roger J Packer
1 reference
Anu Banerjee
1 reference
Regina Jakacki
1 reference
Amar Gajjar
1 reference
Stewart Goldman
1 reference
Ian F Pollack
1 reference
James M Boyett
1 reference
19 September 2013
1 reference
1 reference
4180-4187
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference